Publications by authors named "Petra Prinz"

Claim this Profile
"
"The Sheep Did It Again": Replication of Animal-Assisted Treatment in Psychiatric Inpatients with Substance Use Disorder and Borderline Personality Disorder in a Randomized Controlled Trial.
Petra Schmid, Carmen Nauss, Claudia Jauch-Ederer, Petra Prinz, Anna Lena Kordeuter

Healthcare (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms.
Simone Thomas, Martin Wermke, Vladan Vučinić, Eva Wagner-Drouet, Andreas Mackensen, Petra U Prinz

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies.
Maja Bürdek, Petra U Prinz, Kathrin Mutze, Stefanie Tippmer, Christiane Geiger

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can sheep help to improve positive emotions, mindfulness, and self-efficacy expectancy? A pilot study of animal-assisted intervention as an enhanced CBT-based therapy for substance use disorders.
Petra Schmid, Carmen Nauss, Claudia Jauch-Ederer, Petra Prinz, Stefan Tschöke

Front Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
Yngvar Fløisand, Mats Remberger, Iris Bigalke, Dag Josefsen, Helen Vålerhaugen, Petra U Prinz

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.
Petra U Prinz, Anna N Mendler, Dorothee Brech, Ilias Masouris, Ralph Oberneder

Int J Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma.
Elfriede Noessner, Dorothee Brech, Anna N Mendler, Ilias Masouris, Ramona Schlenker, Petra U Prinz

Oncoimmunology· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation.
Anna N Mendler, Bin Hu, Petra U Prinz, Marina Kreutz, Eva Gottfried

Int J Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
Petra U Prinz, Anna N Mendler, Ilias Masouris, Leopold Durner, Ralph Oberneder

J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.
Judith Eckl, Alexander Buchner, Petra U Prinz, Rainer Riesenberg, Sabine I Siegert

J Mol Med (Berl)· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Ainhoa-M Figel, Dorothee Brech, Petra U Prinz, Ulrike K Lettenmeyer, Judith Eckl

Am J Pathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis